Re-irradiation for Locally Recurrent Lung Cancer: Evidence, Risks and Benefits

被引：24

作者：

Rulach, R. ^{[1
]}

Hanna, G. G. ^{[2
,3
]}

Franks, K. ^{[4
]}

McAleese, J. ^{[2
,3
]}

Harrow, S. ^{[1
]}

机构：

[1] Beatson West Scotland Canc Ctr, Dept Clin Oncol, 1053 Great Western Rd, Glasgow G12 0YN, Lanark, Scotland

[2] Belfast City Hosp, Canc Ctr, Dept Clin Oncol, Belfast, Antrim, North Ireland

[3] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland

[4] St James Univ Hosp, Leeds Teaching Hosp NHS Trust, Leeds Canc Ctr, Leeds, W Yorkshire, England

来源：

CLINICAL ONCOLOGY | 2018年 / 30卷 / 02期

关键词：

Lung cancer; radiotherapy; re-irradiation; retreatment; STEREOTACTIC BODY RADIOTHERAPY; EXTERNAL-BEAM RADIOTHERAPY; THORACIC REIRRADIATION; RADIATION-THERAPY; TUMORS; RETREATMENT; CARCINOMA;

D O I：

10.1016/j.clon.2017.11.003

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

In spite of recent improvements in both the technical delivery of radiotherapy and systemic therapy in the treatment of non-small cell lung cancer, local recurrence rates after radiotherapy remain a significant challenge. In the setting of local relapse after radiotherapy, treatments such as surgical resection or radiofrequency ablation are often not appropriate owing to disease and patient factors. Re-irradiation may be a potential treatment option. This overview considers the published evidence and potential treatment strategies. (C) 2017 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

引用

页码：101 / 109

页数：9

共 32 条

[1]

Aktan Meryem, 2016, Asian Pac J Cancer Prev, V17, P5041

[2] Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non-Small-Cell Lung Cancer [J].